BOTOX Cosmetic Botulinum Toxin Type A
Home
Slide Kits

A Patient’s Guide to BOTOX® Cosmetic Treatment provides valuable information for patients who are considering treatment. This slide kit, for use in patient consultations and seminars, explains how glabellar lines develop, how BOTOX® Cosmetic works, what patients may expect from a procedure, typical results, safety information, and patient testimonials.

Download Patient’s Guide Slide Kit

note: please select save when downloading this file.

The BOTOX® Cosmetic Practice Enhancement Series is designed to provide physicians with materials to educate their patients about BOTOX® Cosmetic. It also describes the practice-building potential of treating patients with BOTOX® Cosmetic.

This slide-lecture kit is divided into 2 modules, providing in-depth information about BOTOX® Cosmetic and appropriate patient types. It also features telephone sales training and office management tips and strategies. 

Program 1: Clinical Information

After reviewing Program 1, the audience will be able to:

  • Describe how wrinkles form
  • Explain how BOTOX® Cosmetic treats glabellar lines
  • Set patient expectations regarding the procedure and typical results
  • Provide important safety information to patients
  • Respond to common patient questions regarding BOTOX® Cosmetic

Download Program 1

Program 2: The Practice Builder

After reviewing Program 2, the audience will be able to:

  • Implement best practices for attracting new patients for treatment with BOTOX® Cosmetic as well as for retaining existing patients
  • Understand the potential role of BOTOX® Cosmetic in building practice volume and increasing demand for additional procedures and services
  • Request materials to facilitate discussions with patients

Download Program 2

BOTOX® Cosmetic is indicated for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in patients 18 to 65 years of age.

Important Safety Information

BOTOX® Cosmetic is contraindicated in the presence of infection at the proposed injection site(s) and in individuals with known hypersensitivity to any ingredient in the formulation. There have been rare reports of adverse events involving the cardiovascular system. Serious and/or immediate hypersensitivity reactions have been reported rarely. These reactions include anaphylaxis, urticaria, soft-tissue edema, and dyspnea.

The most common adverse events following injection include blepharoptosis and nausea. Localized pain, infection, inflammation, tenderness, swelling, erythema and/or bleeding/bruising may be associated with the injection. Patients with neuromuscular disorders such as ALS, myasthenia gravis, or Lambert-Eaton syndrome may be at increased risk of serious adverse events.

Please see the additional safety information and full prescribing information.
Home  |  Prescribing Information  |  Privacy Policy  |  Contact Allergan  |  Site Map
Allergan   © 2006 Allergan, Inc. Irvine, CA 92612.  ® and ™ marks owned by Allergan, Inc.